Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Recruiting · NCT06119269 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2025-06-05 | NCT06119269 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Pisa | 50 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ospedale S. Eugenio ASL 2 Roma | Roma | Italy | 1 |
| Policlinico Milano | Milan | Italy | 1 |
| Santa Chiara University Hospital | Pisa | Italy | 1 |
| University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant | Cagliari | Italy | 1 |
| University of Naples Federico II - Unit of Hematology | Naples | Italy | 1 |